Xanax

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

63 competitors in Cataract

#DrugCompanyPhaseTrials

1

Avelox

Bayer

Approved

32

Eylea

Regeneron

Approved

33

Decadron

AAspen Global Incorporated

Approved

134

Bromday

BBausch Health Americas, Inc.

Approved

105

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

96

Lovenox

Sanofi

Approved

17

Cipro

Bayer

Approved

—8

Voltaren

Novartis

Approved

—9

Deltasone

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

410

Levaquin

WWim Janssens

Approved

3Show 41 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Cataract2 trials

Anxiety and Surgery Satisfaction for Cataract Patient With Different State Anxiety

Recruiting·NNational Taiwan University Hospital·N/A·NCT06826417·400 enrolled

An Extension Test of Whether to Use Oral Anti-anxiety Drugs (XANAX) When Patients Choose Second Eye Cataract Surgery After Unblinding, and Analyze Their Anxiety, Satisfaction and Pain Satisfaction

Recruiting·NNational Taiwan University Hospital·Phase 4·NCT06874452·250 enrolled

LAM1 trial

Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets Under Fed Conditions

Completed·Orion Corporation, Orion Pharma·Phase 1·NCT00878514·18 enrolled

Benzodiazepines1 trial

Opiates and Benzodiazepines on Driving

Completed·TTimothy L. Brown·Phase 4·NCT03447353·18 enrolled

Details

Drug Info

Related News